Publication | Closed Access
The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint
95
Citations
3
References
2022
Year
Pi3k InhibitorsOncologyMedicineHaematological MalignanciesPathologyAnti-cancer AgentCancer TreatmentUltimate Safety EndpointPharmacologyCancer GrowthTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1